APA (7th ed.) Citation

E, G., NS, K., D, P., B, C., A, J., A, A., . . . C, F. (2025). A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: The DREAM TO TREAT AD study protocol. Skin health and disease, 5(3), 196. https://doi.org/10.1093/skinhd/vzaf020

Chicago Style (17th ed.) Citation

E, Gribaleva, et al. "A Pan-European Register-based Observational Study of Abrocitinib and Conventional Systemic Therapies in Moderate and Severe Atopic Dermatitis: The DREAM TO TREAT AD Study Protocol." Skin Health and Disease 5, no. 3 (2025): 196. https://doi.org/10.1093/skinhd/vzaf020.

MLA (9th ed.) Citation

E, Gribaleva, et al. "A Pan-European Register-based Observational Study of Abrocitinib and Conventional Systemic Therapies in Moderate and Severe Atopic Dermatitis: The DREAM TO TREAT AD Study Protocol." Skin Health and Disease, vol. 5, no. 3, 2025, p. 196, https://doi.org/10.1093/skinhd/vzaf020.